NMBHomo sapiens (Human)Cancer cell line

🤖 AI SummaryBased on 12 publications

Quick Overview

Human neuroblastoma cell line with specific opiate binding sites.

Detailed Summary

The NMB cell line is a human neuroblastoma cell line established from a 2-year-old child with metastatic disease. It exhibits specific opiate binding sites, characterized by high stereospecificity for delta-opioid peptides such as D-Ala2-D-Leu5 enkephalin and D-Thr2-D-Leu5 enkephalin. These binding sites are sensitive to trypsin and heat, and show a sodium-dependent decrease in agonist binding. The cell line has been used to study opioid receptor interactions and has been karyotyped to confirm its human origin and genetic stability. Research on NMB has contributed to understanding the pharmacology of opioid peptides and their receptors in neuroblastoma.

Research Applications

Opioid receptor studiesNeuroblastoma cell lineOpiate binding site characterization

Key Characteristics

Specific opiate binding sitesDelta-opioid receptor activitySensitivity to trypsin and heatSodium-dependent binding modulation
Generated on 6/18/2025

Basic Information

Database IDCVCL_2143
SpeciesHomo sapiens (Human)
Tissue SourceBone marrow[UBERON:UBERON_0002371]

Donor Information

0
Age CategoryPediatric
SexFemale
Subtype FeaturesMYC_Amplified

Disease Information

DiseaseNeuroblastoma
LineagePeripheral Nervous System
SubtypeNeuroblastoma
OncoTree CodeNBL

DepMap Information

Source TypeDSMZ
Source IDACH-001367_source

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
11,12
D13S317
11,12
D16S539
9,13
D18S51
17
D19S433
11,13
D21S11
28,29
D2S1338
20,23
D3S1358
15,17
D5S818
11
D7S820
10
D8S1179
14
FGA
22,25
Penta D
5,11
Penta E
13,16
TH01
7,8
TPOX
7,9
vWA
17,18,20
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines.

Hart L.S., Dent M.H., Fortina P., Reynolds C.P., Maris J.M.

Sci. Data 4:170033-170033(2017).

Testing of SNS-032 in a panel of human neuroblastoma cell lines with acquired resistance to a broad range of drugs.

Fichtner I., Ghafourian T., Westermann F., Cinatl J. Jr.

Transl. Oncol. 6:685-696(2013).

PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma.

Opoku-Ansah J., Wada R.K., Bachmann A.S., Ramos J.W.

Int. J. Cancer 131:1556-1568(2012).

NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome.

Messiaen L.M., Versteeg R., Bernards R.

Cell 142:218-229(2010).

Identification of ALK as a major familial neuroblastoma predisposition gene.

Maris J.M.

Nature 455:930-935(2008).

Mutations in PIK3CA are infrequent in neuroblastoma.";

Dam V., Morgan B.T., Mazanek P., Hogarty M.D.

BMC Cancer 6:177.1-177.10(2006).

High-resolution detection and mapping of genomic DNA alterations in neuroblastoma.

Maris J.M.

Genes Chromosomes Cancer 43:390-403(2005).

Combined M-FISH and CGH analysis allows comprehensive description of genetic alterations in neuroblastoma cell lines.

Salwen H.R., Laureys G., Manoel N., De Paepe A., Speleman F.

Genes Chromosomes Cancer 32:126-135(2001).

Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour.

Gilbert F., Brodeur G.M., Goldstein M.N., Trent J.M.

Nature 305:245-248(1983).

NMB: a human neuroblastoma cell line with specific opiate binding sites.

Ard M.D., Goldstein M.N., Nash D.R., Gottlieb D.I.

Biochem. Biophys. Res. Commun. 133:60-66(1985).

Chromosomal aberrations in human neuroblastomas.";

Brodeur G.M., Sekhon G.S., Goldstein M.N.

Cancer 40:2256-2263(1977).

Double minute chromosomes and the homogeneously staining regions in chromosomes of a human neuroblastoma cell line.

Balaban-Malenbaum G.B., Gilbert F.

Science 198:739-741(1977).

Tumor cell lines of the peripheral nervous system.";

Israel M.A., Thiele C.J.

(In book chapter) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.43-78; Academic Press; New York; USA (1994).

Homogeneously staining regions and double minute chromosomes, prevalent cytogenetic abnormalities of human neuroblastoma cells.

Biedler J.L., Meyers M.B., Spengler B.A.

(In book chapter) Advances in cellular neurobiology, Vol. 4; Fedoroff S., Hertz L. (eds.); pp.267-307; Academic Press; New York; USA (1983).